Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort descending

Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky

 May 2017 The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer The Oncologist

Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina

 May 2015 Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure The Oncologist

Angela K. Green, Katherine E. Reeder-Hayes, Robert W. Corty, Ethan Basch, Mathew I. Milowsky, Stacie B. Dusetzina, Antonia V. Bennett, William A. Wood

 May 2017 The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data The Oncologist

Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky

 May 2015 The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer The Oncologist

Saki Nishiyama, Mamoru Narukawa

 February 2022 Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials The Oncologist

Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor

 April 2018 Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer The Oncologist

Celine Yeh, Mengxi Zhou, Keith Sigel, Gayle Jameson, Ruth White, Rachael Safyan, Yvonne Saenger, Elizabeth Hecht, John Chabot, Stephen Schreibman, Béata Juzyna, Marc Ychou, Thierry Conroy, Tito Fojo, Gulam A Manji, Daniel Von Hoff, Susan E Bates

 November 2022 Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data The Oncologist

Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Terek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group

 May 2018 Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action The Oncologist

Fadi S. Dahdaleh, Scott K. Sherman, Elizabeth C. Poli, Janani Vigneswaran, Blase N. Polite, Manish R. Sharma, Daniel V. Catenacci, Steven B. Maron, Kiran K. Turaga

 October 2018 Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial Surgery

Omar Abdel-Rahman

 December 2018 Statin Treatment and Outcomes of Metastatic Pancreatic Cancer: A Pooled Analysis of Two Phase III Studies Clinical and Translational Oncology

Omar Abdel-Rahman

 June 2018 Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial Clinical and Translational Oncology

Omar Abdel‐Rahman, S. Ghosh, and J. Walker

 February 2020 Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials Clinical and Translational Oncology

Omar Abdel-Rahman

 December 2019 Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials Clinical Colorectal Cancer

Omar Abdel-Rahman

 December 2018 5-Fluorouracil-Related Cardiotoxicity; Findings from Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer Clinical Colorectal Cancer

Pages